WHY: Rosen Law Firm, a global investor rights law firm, reminded purchasers of securities of Fulcrum Therapeutics Inc., (NASDAQ: FULC) between March 3, 2022 and March 8, 2023, both dates inclusive (the “Class Period”), of the important June 27, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Fulcrum securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Fulcrum class action, go to or call Phillip

Final FTC Rule on Non-Competing Not Expected Before April 2024

According to Bloomberg, The Federal Trade Commission (“FTC”) is not expected to vote on the final version of a new rule that would ban non-compete clauses in employment contracts until April 2024. The rule defines a “non-compete clause” as “ a contractual term between an employer and a worker that prevents the worker from seeking or accepting employment with a person, or operating a business, after the conclusion of the worker’s employment with the employer.”

As we previously reported, the proposed rule would ban employers from imposing noncompete agreements on their employees. The rule would also require employers to accept …

The Schall Law Firm Encourages Investors in Nutanix, Inc. with Losses of $100,000 to Contact the Firm


Published May 23, 2023

LOS ANGELES, CA / ACCESSWIRE / May 22, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutanix, Inc. (“Nutanix” or “the Company”) (NASDAQ:NTNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the US Securities and Exchange Commission .

The Schall Law Firm, Thursday, May 18, 2023, Press release picture

Investors who purchased the Company’s securities between September 21, 2021 and March 6, 2023, inclusive (the “Class Period”), are encouraged to contact the firm before June 13, 2023.

If you are a shareholder